mogamulizumab · Medicine question

How does mogamulizumab target cancer cells?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Mogamulizumab selectively binds to CCR4, a receptor on some cancer cells, including certain T-cell malignancies, resulting in depletion of these target cells.

Sources for this answer

Poteligeo 4 mg/mL, Concentrate for Solution for InfusionKyowa Kirin Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 8Document updated 12 November 2025

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

Can mogamulizumab affect the ability to drive or use machines?Have the safety and efficacy of Poteligeo (mogamulizumab) been established in children under 18?How long should women of childbearing potential use effective contraception during and after mogamulizumab treatment?How much sodium does Poteligeo (mogamulizumab) contain per dose?What does Poteligeo (mogamulizumab) concentrate for solution for infusion look like?What is known about the effect of mogamulizumab on human fertility?

loading page…

Answer

Sources for this answer

More questions about mogamulizumab

Answer

Sources for this answer

More questions about mogamulizumab

mogamulizumab

More clinical questions?